Read more

October 22, 2021
1 min read
Save

Top in rheumatology: COVID-19 biomarker, vaccination in children with rheumatic diseases

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers found that plasma osteopontin levels were higher in children hospitalized with moderate to severe COVID-19 and MIS-C, suggesting this could be a “reliable biomarker” for disease severity.

A review of the data was the top story in rheumatology last week.

Doctor Holding Test Tube That Reads COVID-19
Source: Adobe Stock

Another top story was about rising COVID-19 rates among children during the back-to-school season and what providers need to know about vaccination in young children with rheumatic diseases.

Read these and more top stories in rheumatology below:

Plasma osteopontin may offer 'reliable biomarker' to predict COVID-19, MIS-C severity

Plasma osteopontin levels are significantly higher in children hospitalized with moderate to severe COVID-19 and MIS-C than in those with mild or asymptomatic cases, suggesting a potential biomarker for disease severity, researchers said. Read more.

COVID-19 vaccines for young children with rheumatic diseases: What providers need to know

The fight against COVID-19 has shifted drastically since the beginning of 2021. The front lines are no longer nursing homes or retirement communities, but school cafeterias and daycare centers. Read more.

Antibiotics exposure in early life linked to juvenile idiopathic arthritis

Exposure to antibiotics in early life is associated with the later onset of juvenile idiopathic arthritis, according to data published in Pediatric Rheumatology. Read more.

Enthesitis-related arthritis, family history, etanercept use tied to IBD risk in JIA

Enthesitis-related arthritis and a family history of autoimmune disease are key risk factors for inflammatory bowel disease in juvenile idiopathic arthritis, according to data published in Rheumatology. Read more.

Elderly patients with SLE, breast cancer at increased risk for mortality

Systemic lupus erythematosus is a risk factor for increased mortality in elderly patients with early breast cancer, according to data published in Arthritis Care & Research. Read more.